01-05-2008 | Original Articles
Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial
Published in: Journal of Nuclear Cardiology | Issue 3/2008
Login to get access